# National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

> **NCT00097539** · — · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 65205 (actual)

## Conditions studied

- Growth Disorders

## Interventions

- **BIOLOGICAL:** Somatrem
- **BIOLOGICAL:** Somatropin

## Key facts

- **NCT ID:** NCT00097539
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1985-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 65205 (ACTUAL)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097539, "National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT00097539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*